Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Proposed Issue and Placing
Investegate announcements from Faron Pharma. Oy, Proposed Issue and Placing
Stay updated with breaking news from Therapy Acceleration Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Faron Pharma. Oy, Proposed Issue and Placing
17.01.2023 - Strategic equity investment of USD 3 million to support clinical advancement of BI-1206 in Non-Hodgkin's LymphomaSupports also clinical development of BI-1808 in cutaneous T-cell lymphomaLLS TAP is a strategic funding initiative to accelerate ... Seite 1
Strategic equity investment of USD 3 million to support clinical advancement of BI-1206 in Non-Hodgkin's LymphomaSupports also clinical development of BI-1808 in cutaneous T-cell lymphomaLLS TAP is a strategic
KRAKOW, Poland, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Ryvu Therapeutics [WSE:RVU], a clinical-stage drug discovery and development company focusing on novel...
/PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) recognized and celebrated the outstanding contributions of six LLS-funded scientific investigators for...